Related Articles for PubMed (Select 18694493)

Novel therapies in genitourinary cancer: an update.

Chu D, Wu S.

J Hematol Oncol. 2008 Aug 11;1:11.

PMID: 18694493 [PubMed - in process]

Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.

Grubb RL 3rd, Behari A, Kim CM, Williams CR, Linehan WM, Coleman JA.

J Urol. 2005 Dec;174(6):2330-3.

PMID: 16280834 [PubMed - indexed for MEDLINE]

Experimental therapy for advanced renal cell carcinoma.

Hutson TE, Figlin RA.

Expert Opin Investig Drugs. 2008 Nov;17(11):1693-702. Review.

PMID: 18922106 [PubMed - in process]

The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics.

Wong MK.

Curr Oncol Rep. 2008 May;10(3):259-63. Review.

PMID: 18765157 [PubMed - indexed for MEDLINE]

Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.

Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Dekernion JB, Pantuck AJ.

Cancer. 2008 Nov 1;113(9):2457-63.

PMID: 18823034 [PubMed - indexed for MEDLINE]

Molecularly targeted therapy for hepatocellular carcinoma.

Tanaka S, Arii S.

Cancer Sci. 2009 Jan;100(1):1-8. Epub 2008 Nov 25.

PMID: 19038007 [PubMed - in process]

10:

Systemic therapy for metastatic renal cell carcinoma.

Kroog GS, Motzer RJ.

Urol Clin North Am. 2008 Nov;35(4):687-701.

PMID: 18992622 [PubMed - in process]

11:

Targeted therapy for advanced renal cell cancer: cytokines and beyond.

Papaetis GS, Karapanagiotou LM, Pandha H, Syrigos KN.

Curr Pharm Des. 2008;14(22):2229-51. Review.

PMID: 18781974 [PubMed - indexed for MEDLINE]

12:

Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.

Schlesinger-Raab A, Treiber U, Zaak D, Hölzel D, Engel J.

Eur J Cancer. 2008 Nov;44(16):2485-95. Epub 2008 Sep 8.

PMID: 18783939 [PubMed - in process]

13:

An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma.

Haghighat P, Bekaii-Saab T.

J Natl Compr Canc Netw. 2008 Oct;6(9):895-900.

PMID: 18926099 [PubMed - in process]

14:

New targeted therapies and small-cell lung cancer.

Rossi A, Maione P, Palazzolo G, Sacco PC, Ferrara ML, Falanga M, Gridelli C.

Clin Lung Cancer. 2008 Sep;9(5):271-9. Review.

PMID: 18824449 [PubMed - indexed for MEDLINE]

15:

Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update.

Kruck S, Kuczyk MA, Gakis G, Kramer MW, Stenzl A, Merseburger AS.

Rev Recent Clin Trials. 2008 Sep;3(3):212-6. Review.

PMID: 18782079 [PubMed - indexed for MEDLINE]

16:

Current and emerging treatments for multiple myeloma.

Schwartz RN, Vozniak M.

J Manag Care Pharm. 2008 Sep;14(7 Suppl):12-9. Review.

PMID: 18774881 [PubMed - indexed for MEDLINE]

17:

[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006]

Reinacher-Schick A, Arnold D, Lordick F, Möhler M, Lutz MP, Seufferlein T; American Society of Clinical Oncology/ASCO 2006.

Z Gastroenterol. 2006 Oct;44(10):1065-72. German.

PMID: 17063436 [PubMed - indexed for MEDLINE]

18:

Current dendrimer applications in cancer diagnosis and therapy.

Majoros IJ, Williams CR, Baker JR Jr.

Curr Top Med Chem. 2008;8(14):1165-79. Review.

PMID: 18855703 [PubMed - indexed for MEDLINE]

19:

Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies.

Hutson TE, Figlin RA, Kuhn JG, Motzer RJ.

Oncologist. 2008 Oct;13(10):1084-96. Epub 2008 Oct 6.

PMID: 18838439 [PubMed - in process]

20:

Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives.

Hopfner M, Schuppan D, Scherubl H.

World J Gastroenterol. 2008 Dec 14;14(46):7021-32.

PMID: 19084910 [PubMed - in process]

Recent Activity